• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[猫体内可待麦拉、异丙肾上腺素和多巴酚丁胺心血管作用的比较]

[Comparison of the cardiovascular actions of Cordemcura, isoprenaline and dobutamine in cats].

作者信息

Al Mudhaffar A, Hübler D, Schilling G, Chemnitius K H

出版信息

Pharmazie. 1986 Mar;41(3):199-201.

PMID:3714796
Abstract

A comparative study was made of the closed-chest cardiovascular effects of Cordemcura (amrinone), isoprenaline, and dobutamine in anaesthetized cats (n = 17). The haemodynamic parameters used for this purpose include: maximum rate of both left ventricular pressure rise (dp/dtmax) and decline (dp/dtmin), heart frequency (HFR), arterial blood pressure, both systolic (Ps) and diastolic (Pd). The maximum changes of the haemodynamic parameters after increasing iv. bolus injections of the test substances were used to plot the dose-effect curves of the single parameters for each substance. All the 3 pharmaceuticals caused dp/dtmax to rise, with quantitative differences being found. Moreover, quantitatively different positive chronotropic effects have been found. The influence on the remaining haemodynamic parameters was different both in the quantitative and in the qualitative sense. The results were discussed with regard to comparing the cardiovascular effects of Cordemcura with isoprenaline and dobutamine.

摘要

对17只麻醉猫进行了一项比较研究,观察氨力农(强心胺)、异丙肾上腺素和多巴酚丁胺对闭胸心血管系统的影响。用于此目的的血流动力学参数包括:左心室压力上升(dp/dtmax)和下降(dp/dtmin)的最大速率、心率(HFR)、动脉血压,包括收缩压(Ps)和舒张压(Pd)。静脉注射受试物质大剂量后血流动力学参数的最大变化用于绘制每种物质单个参数的剂量-效应曲线。所有这三种药物均使dp/dtmax升高,且存在量的差异。此外,还发现了量的不同的正性变时效应。对其余血流动力学参数的影响在量和质两方面均有所不同。结合比较氨力农与异丙肾上腺素和多巴酚丁胺对心血管系统的影响对结果进行了讨论。

相似文献

1
[Comparison of the cardiovascular actions of Cordemcura, isoprenaline and dobutamine in cats].[猫体内可待麦拉、异丙肾上腺素和多巴酚丁胺心血管作用的比较]
Pharmazie. 1986 Mar;41(3):199-201.
2
[Comparison of the action of Cordemcura on selected cardiovascular parameters following intraduodenal and intravenous application in beagles].
Pharmazie. 1986 Mar;41(3):196-9.
3
[The cardiovascular effect of Cordemcura on various animal models in vivo].[考地马库拉对多种体内动物模型的心血管作用]
Pharmazie. 1986 Mar;41(3):194-5.
4
Dose-related cardiovascular effects of amrinone during enflurane anesthesia in the dog.氨力农在犬安氟醚麻醉期间的剂量相关心血管效应。
Anesth Analg. 1986 Aug;65(8):849-52.
5
In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.新型正性肌力药物3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基)-1-哌嗪基]-2(1H)-喹啉酮(OPC-8212)在多种动物体内和体外的研究。
Arzneimittelforschung. 1984;34(3A):342-6.
6
Hemodynamic effects of amrinone in dogs anesthetized with halothane: comparison with isoproterenol and dobutamine.氨力农对氟烷麻醉犬的血流动力学影响:与异丙肾上腺素和多巴酚丁胺的比较。
Res Commun Chem Pathol Pharmacol. 1984 Jun;44(3):347-54.
7
[Dose-dependent effect of amrinone on hemodynamics, myocardial circulation and myocardial energy requirement. An experimental study].[氨力农对血流动力学、心肌循环及心肌能量需求的剂量依赖性效应。一项实验研究]
Z Kardiol. 1985 Feb;74(2):76-84.
8
Effects of amrinone on contraction and K+-induced contracture of normal and subacutely failed cat ventricular muscle.氨力农对正常及亚急性衰竭猫心室肌收缩和钾诱导挛缩的影响。
Circulation. 1986 Mar;73(3 Pt 2):III36-45.
9
Positive inotropic effect of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212) in the dog with experimentally-induced right-sided heart failure.3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基)-1-哌嗪基]-2(1H)-喹啉酮(OPC-8212)对实验性诱导的犬右侧心力衰竭的正性肌力作用。
Arzneimittelforschung. 1984;34(3A):390-3.
10
Cardiovascular effects of the new positive inotropic agent denopamine with special reference to species difference and the effect on failing heart.新型正性肌力药多巴胺的心血管效应,特别涉及种属差异及对衰竭心脏的作用
Arzneimittelforschung. 1986 Jul;36(7):1063-8.